Hussain I, Powell D, Howlett D R, Tew D G, Meek T D, Chapman C, Gloger I S, Murphy K E, Southan C D, Ryan D M, Smith T S, Simmons D L, Walsh F S, Dingwall C, Christie G
Department of Neurosciences, SmithKline Beecham Pharmaceuticals, Harlow, Essex, United Kingdom.
Mol Cell Neurosci. 1999 Dec;14(6):419-27. doi: 10.1006/mcne.1999.0811.
The Alzheimer's disease beta-amyloid peptide (Abeta) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of beta- and then gamma-secretases. Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of beta-secretase. Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-associated C-terminal beta-secretase APP fragment. Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the production of the fragments characteristic of cleavage at the beta-secretase site. The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Abeta. Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.
阿尔茨海默病β-淀粉样肽(Aβ)是由β-分泌酶和γ-分泌酶依次作用,从1型整合膜糖蛋白淀粉样前体蛋白(APP)上切割产生的。在此我们报告,一种新型跨膜天冬氨酸蛋白酶Asp 2具有β-分泌酶预期的关键活性。在表达APP的细胞中瞬时表达Asp 2会导致APP N端片段分泌增加以及细胞相关的C端β-分泌酶APP片段增加。Asp 2中两个假定的催化天冬氨酰残基中的任何一个发生突变,都会消除β-分泌酶位点切割所特有的片段产生。该酶存在于正常和阿尔茨海默病(AD)大脑中,在已知产生Aβ的细胞系中也能发现。Asp 2在转染细胞中定位于高尔基体/内质网,并且在稳定表达751个氨基酸异构体APP的细胞中与APP明显共定位。